keyword
MENU ▼
Read by QxMD icon Read
search

immune thrombocytopenia chronic lymphatic leukemia treatment

keyword
https://www.readbyqxmd.com/read/22185370/thrombopoietin-receptor-agonists-in-haematological-disorders-the-danish-experience
#1
Sif Gudbrandsdottir, Henrik Frederiksen, Hans Hasselbalch
The objective of this study was to investigate the use of thrombopoietin-receptor agonists (TPO-ra) in patients with refractory primary immune thrombocytopenia (ITP) as well as off-label use of TPO-ra in Danish haematology departments. Hospital medical records from 32 of the 39 patients having received TPO-ra from 2009 to 1 May 2011 were available for data collection and included in the study. Of these patients, 15 received TPO-ra for refractory primary ITP, 7 for secondary ITP (chronic lymphatic leukaemia, systemic lupus erythematosus, Evans syndrome, human immunodeficiency virus and celiac disease) and 10 were treated for non-ITP (chemotherapy-induced, acute myeloid leukaemia, myelodysplastic syndrome, hereditary spherocytosis and suspected chemically induced thrombocytopenia)...
2012: Platelets
https://www.readbyqxmd.com/read/15763982/fatal-thrombocytopaenia-temporally-related-to-the-administration-of-alemtuzumab-mabcampath-for-refractory-cll-despite-early-discontinuation-of-therapy
#2
Imran Haider, Mary Cahill
Alemtuzumab (Campath 1H -MabCampath), initially used for prophylaxis of graft versus host disease in allogenic transplantaion, is now increasingly used for refractory chronic lymphatic leukaemia (CLL). Its efficacy has been well documented in this--the commonest form of leukaemia. Alemtuzumab is associated with severe immunosuppression, allergic reactions and thrombocytopenia. Data sheet and information supplied by the manufacturer confirm the rare occurrence of serious immune thrombocytopenia, recommending discontinuation of therapy when platelet counts fall below 50x10(9)/l...
October 2004: Hematology (Amsterdam, Netherlands)
https://www.readbyqxmd.com/read/10645065/-splenectomy-in-immune-thrombocytopenia-and-other-hematological-diseases
#3
COMPARATIVE STUDY
S Lanzi, G P Lancini, T Piardi, F Biasca, G M Ottaviani, G Rossi, C Pizzoccaro, A Pouchè
The Authors report a retrospective study of 74 splenectomies performed for hematologic diseases. The role of splenectomy has changed over recent years with increased indications for immune thrombocytopenic purpura (ITP). The aim of this study was to assess indications to surgery in relation to clinical presentation with typical hemorrhagic features or severe thrombocytopenia only; interval between onset of symptoms and splenectomy; failure of medical management and complications from steroid administration; scintigraphic studies predictive of response to splenectomy and preoperative treatment in patients with severe thrombocytopenia were also studied...
November 1999: Il Giornale di Chirurgia
https://www.readbyqxmd.com/read/3250787/high-dose-intravenous-immunoglobulin-in-the-treatment-of-autoimmune-haemolytic-anaemia
#4
R V Majer, R D Hyde
Conventional doses of intravenous immunoglobulin (i.v. Ig) (0.4 g/kg/day for 5 days) commonly produce a remission in immune thrombocytopenia (ITP) but have only rarely been successful in autoimmune haemolytic anaemia (AIHA). There are a few reports of higher doses of i.v. Ig being more effective in AIHA. We have treated two patients with AIHA with high-dose i.v. Ig (0.5 g/kg/day for 5 days). In one patient with an associated ITP a prompt rise in platelet count but no change in Hb concentration occurred. The second patient with AIHA associated with chronic lymphatic leukaemia showed a prompt response, with a rise in Hb concentration and fall in plasma bilirubin...
1988: Clinical and Laboratory Haematology
https://www.readbyqxmd.com/read/2670653/-thymopentin-in-a-case-of-autoimmune-thrombocytopenia-secondary-to-chronic-lymphatic-leukemia
#5
M Cantore, A Bucalossi, P Butini, A Carnevali, M A Cavion, L Leoncini
The Authors describe a case of chronic lymphocytic leukemia complicated by immune thrombocytopenic purpura. They consider the various causes of thrombocytopenia during lympho-proliferative disorders and underline the different prognostic significance. They evaluate the efficacy of treatment with timopentina.
June 1989: Giornale di Clinica Medica
https://www.readbyqxmd.com/read/2148838/-treatment-with-cyclosporin-a-of-the-anemia-associated-with-chronic-lymphatic-leukemia
#6
REVIEW
M Rozman, E Montserrat, F Cervantes, J Bladé, P Marín, C Rozman
The anaemia accompanying chronic lymphocytic leukaemia (CLL) may have different causes (bone marrow infiltration, hypersplenism, immune haemolysis, haemorrhages) and is one of the poor-prognosis features of the disease. Treatment of advanced CLL patients with tumoral-infiltrative anaemia is based on chemotherapy. Nevertheless, some proofs seem to stress the important role played by suppressor T cells on the mechanism of the anaemia in such patients. As a result of these observations, cyclosporin A, a drug with proven efficacy in autoimmune diseases and bone marrow insufficiency, is being used in these cases...
August 1990: Sangre
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"